NO864879L - Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.

Info

Publication number: NO864879L
Authority: NO; Norway
Prior art keywords: tiazolo; compounds; procedure; preparation; therapeutic active
Prior art date: 1985-12-05

Application number

NO864879A

Other languages

English (en)

Other versions

NO864879D0 (no

NO165397C (no

NO165397B (no

Inventor

Ikuo Ueda

Masaaki Matsuo

Takashi Manabe

Hiroshi Matsuda

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-12-05

Filing date

1986-12-04

Publication date

1987-06-09

1986-12-04 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1986-12-04 Publication of NO864879D0 publication Critical patent/NO864879D0/no

1987-06-09 Publication of NO864879L publication Critical patent/NO864879L/no

1990-10-29 Publication of NO165397B publication Critical patent/NO165397B/no

1991-02-06 Publication of NO165397C publication Critical patent/NO165397C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO864879A 1985-12-05 1986-12-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. NO165397C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP27446585		1985-12-05
JP23687986		1986-10-03

Publications (4)

Publication Number	Publication Date
NO864879D0 NO864879D0 (no)	1986-12-04
NO864879L true NO864879L (no)	1987-06-09
NO165397B NO165397B (no)	1990-10-29
NO165397C NO165397C (no)	1991-02-06

Family

ID=26532916

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO864879A NO165397C (no)	1985-12-05	1986-12-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.

Country Status (20)

Country	Link
US (1)	US4742057A (no)
EP (1)	EP0224919B1 (no)
JP (1)	JPS63225374A (no)
KR (1)	KR890003356B1 (no)
CN (1)	CN1017707B (no)
AR (1)	AR242574A1 (no)
AT (1)	ATE66224T1 (no)
AU (1)	AU601911B2 (no)
CA (1)	CA1311754C (no)
DE (1)	DE3680877D1 (no)
DK (1)	DK575386A (no)
ES (1)	ES2040206T3 (no)
FI (1)	FI87212C (no)
GR (1)	GR3002606T3 (no)
HU (1)	HU207315B (no)
IE (1)	IE59624B1 (no)
IL (1)	IL80729A0 (no)
NO (1)	NO165397C (no)
PH (1)	PH23004A (no)
SU (2)	SU1597102A3 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE58370B1 (en) *	1985-04-10	1993-09-08	Lundbeck & Co As H	Indole derivatives
GB8726763D0 (en) *	1987-11-16	1987-12-23	Fujisawa Pharmaceutical Co	Thiazole compounds
DK733788A (da) *	1988-01-14	1989-07-15	Fujisawa Pharmaceutical Co	Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB8908085D0 (en) *	1989-04-11	1989-05-24	Lundbeck & Co As H	New therapeutic use
US5238945A (en) *	1989-04-11	1993-08-24	H. Lundbeck A/S	Method of treating psychoses
US5643784A (en) *	1990-12-04	1997-07-01	H, Lundbeck A/S	Indan derivatives
NZ243065A (en) *	1991-06-13	1995-07-26	Lundbeck & Co As H	Piperidine derivatives and pharmaceutical compositions
JP2600644B2 (ja) *	1991-08-16	1997-04-16	藤沢薬品工業株式会社	チアゾリルベンゾフラン誘導体
DK78692D0 (da) *	1992-06-12	1992-06-12	Lundbeck & Co As H	Dimere piperidin- og piperazinderivater
US5457099A (en) *	1992-07-02	1995-10-10	Sawai Pharmaceutical Co., Ltd.	Carbostyril derivatives and antiallergic agent
JP3719612B2 (ja) *	1993-06-14	2005-11-24	塩野義製薬株式会社	ヘテロ環を含有する尿素誘導体
US5521196A (en) *	1994-10-05	1996-05-28	Eli Lilly And Company	5-HT1F agonists for the treatment of migraine
US5521197A (en) *	1994-12-01	1996-05-28	Eli Lilly And Company	3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
EA001113B1 (ru) *	1995-03-20	2000-10-30	Эли Лилли Энд Компани	5-замещенные-3-(1,2,3,6-тетрагидропиридин-4-ил)- и 3-(пиперидин-4-ил)-1н-индолы и их фармацевтически приемлемые соли и сольваты, фармацевтическая композиция на их основе, способ активации рецепторов 5-нт1 и способ ингибирования нейронной белковой транссудации
CZ168896A3 (en) *	1995-06-27	1997-01-15	Egyt Gyogyszervegyeszeti Gyar	Oxaindene derivatives and process for preparing thereof
ES2165274B1 (es)	1999-06-04	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
ES2172436B1 (es) *	2000-10-31	2004-01-16	Almirall Prodesfarma Sa	Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
ES2201907B1 (es)	2002-05-29	2005-06-01	Almirall Prodesfarma, S.A.	Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
GB0328909D0 (en) *	2003-12-12	2004-01-14	Syngenta Participations Ag	Chemical compounds
CN101541765A (zh) *	2005-10-24	2009-09-23	詹森药业有限公司	3-哌啶-4-基吲哚orl-1受体调节剂
EA029499B9 (ru) *	2013-08-02	2018-07-31	Пфайзер Инк	Ингибиторы rorc2 и способы их применения
US20150315179A1 (en)	2014-05-02	2015-11-05	Torrey Pines Institute For Molecular Studies	Compounds and methods of treating neurological disorders
EP3250570A1 (en)	2015-01-30	2017-12-06	Pfizer Inc	Methoxy-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
JP2018510131A (ja)	2015-01-30	2018-04-12	ファイザー・インク	Ｒｏｒｃ２のスルホンアミド置換インドールモジュレーターおよびその使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3361759A (en) *	1963-10-07	1968-01-02	Upjohn Co	3-(2-pyrrolidinyl)-indoles and method of preparation
FR2193584B1 (no) *	1972-07-28	1975-08-08	Roussel Uclaf
US3873559A (en) *	1973-03-30	1975-03-25	Squibb & Sons Inc	Heterocyclic carboxamido thiazolinyl indoles
DE2322470A1 (de) *	1973-05-04	1974-11-21	Boehringer Sohn Ingelheim	Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
IL48508A (en) *	1974-12-09	1979-10-31	Roussel Uclaf	Pharmaceutical compositions comprising piperidylindole derivatives
FR2349331A1 (fr) *	1976-04-30	1977-11-25	Roussel Uclaf	Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments
FR2362628A1 (fr) *	1976-08-26	1978-03-24	Roussel Uclaf	Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
FR2421899A1 (fr) *	1978-01-16	1979-11-02	Roussel Uclaf	Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
FR2426465B1 (no) *	1978-01-16	1983-04-29	Roussel Uclaf
FR2460947A1 (fr) *	1979-07-13	1981-01-30	Roussel Uclaf	Nouveau derives n-substitues du tetrahydropyridinyl-indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4359468A (en)	1981-02-25	1982-11-16	Boehringer Ingelheim Ltd.	Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
FR2533924A1 (fr) *	1982-10-05	1984-04-06	Roussel Uclaf	Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
US4548939A (en) *	1984-10-01	1985-10-22	Janssen Pharmaceutica N. V.	1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
IE58370B1 (en) *	1985-04-10	1993-09-08	Lundbeck & Co As H	Indole derivatives

1986
- 1986-11-20 US US06/932,592 patent/US4742057A/en not_active Expired - Fee Related
- 1986-11-23 IL IL80729A patent/IL80729A0/xx not_active IP Right Cessation
- 1986-11-25 CA CA000523787A patent/CA1311754C/en not_active Expired - Fee Related
- 1986-11-25 IE IE310386A patent/IE59624B1/en not_active IP Right Cessation
- 1986-11-28 PH PH34537A patent/PH23004A/en unknown
- 1986-11-28 AU AU65810/86A patent/AU601911B2/en not_active Ceased
- 1986-11-28 DK DK575386A patent/DK575386A/da not_active Application Discontinuation
- 1986-12-01 FI FI864879A patent/FI87212C/fi not_active IP Right Cessation
- 1986-12-03 EP EP86116829A patent/EP0224919B1/en not_active Expired - Lifetime
- 1986-12-03 DE DE8686116829T patent/DE3680877D1/de not_active Expired - Fee Related
- 1986-12-03 ES ES198686116829T patent/ES2040206T3/es not_active Expired - Lifetime
- 1986-12-03 AT AT86116829T patent/ATE66224T1/de not_active IP Right Cessation
- 1986-12-04 JP JP61289450A patent/JPS63225374A/ja active Pending
- 1986-12-04 SU SU864028638A patent/SU1597102A3/ru active
- 1986-12-04 NO NO864879A patent/NO165397C/no unknown
- 1986-12-04 HU HU865027A patent/HU207315B/hu not_active IP Right Cessation
- 1986-12-05 KR KR1019860010414A patent/KR890003356B1/ko not_active IP Right Cessation
- 1986-12-05 CN CN86108205A patent/CN1017707B/zh not_active Expired
- 1986-12-05 AR AR86306103A patent/AR242574A1/es active
1988
- 1988-07-12 SU SU884356048A patent/SU1753948A3/ru active
1991
- 1991-08-26 GR GR91400945T patent/GR3002606T3/el unknown

Also Published As

Publication number	Publication date
SU1597102A3 (ru)	1990-09-30
DK575386D0 (da)	1986-11-28
DE3680877D1 (de)	1991-09-19
NO864879D0 (no)	1986-12-04
EP0224919A2 (en)	1987-06-10
EP0224919A3 (en)	1988-03-30
AU601911B2 (en)	1990-09-20
HU207315B (en)	1993-03-29
IL80729A0 (en)	1987-02-27
AR242574A1 (es)	1993-04-30
EP0224919B1 (en)	1991-08-14
CN86108205A (zh)	1987-06-17
IE59624B1 (en)	1994-03-09
ATE66224T1 (de)	1991-08-15
CA1311754C (en)	1992-12-22
CN1017707B (zh)	1992-08-05
JPS63225374A (ja)	1988-09-20
US4742057A (en)	1988-05-03
SU1753948A3 (ru)	1992-08-07
HUT46320A (en)	1988-10-28
ES2040206T3 (es)	1993-10-16
NO165397C (no)	1991-02-06
FI87212B (fi)	1992-08-31
FI87212C (fi)	1992-12-10
DK575386A (da)	1987-06-06
KR890003356B1 (ko)	1989-09-19
PH23004A (en)	1989-02-24
FI864879A (fi)	1987-06-06
IE863103L (en)	1987-06-05
FI864879A0 (fi)	1986-12-01
GR3002606T3 (en)	1993-01-25
AU6581086A (en)	1987-06-11
KR870006039A (ko)	1987-07-08
NO165397B (no)	1990-10-29

Publication	Publication Date	Title
NO871267D0 (no)	1987-03-26	Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO864126D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO163406C (no)	1990-05-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO871266L (no)	1987-09-28	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO862477D0 (no)	1986-06-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO870526L (no)	1987-08-13	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874869L (no)	1988-05-25	Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO864879L (no)	1987-06-09	Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO874032D0 (no)	1987-09-25	Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO864674D0 (no)	1986-11-21	Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883485D0 (no)	1988-08-05	Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO890155D0 (no)	1989-01-13	Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO167570C (no)	1991-11-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser.
NO164295C (no)	1990-09-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO164897C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO880667D0 (no)	1988-02-16	Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO165069C (no)	1990-12-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO164899C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO865012L (no)	1987-06-15	Fremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater.
NO864101L (no)	1987-04-21	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO162072C (no)	1989-11-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO882281D0 (no)	1988-05-25	Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO871907D0 (no)	1987-05-07	Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.